Spinout Companies

ChromaTwist is a leader in the research and development of large Stokes Shift fluorescent dyes. The highly tuneable technology is applicable for a broad range of applications, specifically in the biological, biotechnological and medical imaging fields, as well as in medical diagnostics, and in particular flow cytometry.

Irresistible Materials (IM) develops novel materials that address the semiconductor industry’s need for ever-decreasing microchip feature sizes. IM has developed a comprehensive intellectual property portfolio, including patents covering materials and processes for applications in next generation lithography.

Cytox Group Limited provides non-invasive risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway.

Linear Diagnostics deliver enhanced diagnostic solutions through novel technology. The company utilises a patented linear dichroism which enables the rapid detection of multiple targets using a disposable cartridge run on a small low-cost instrument.

4D Biomaterials is dedicated to developing novel solutions for the targeted and controlled regeneration of human tissue.

AltaBioscience provides analytical laboratory services in addition to custom syntheses of peptides, DNA oligos and both polyclonal and monoclonal antibodies. Our testing services include amino acid analysis and protein sequencing in addition to other mass spec analytical techniques.

Microbes NG provide an innovative microbial sequencing service.

Founded in 2010, The Native Antigen Company specialises in the development and manufacture of native and recombinant antigens, antibodies and immunoassays, as well as bespoke product development and custom manufacturing. From the outset, the Company has put itself at the commercial frontline in the fight against infectious disease, using a proprietary, nimble and flexible approach for the design, production and purification of antigens from viruses and bacteria.

In February 2020, it was amongst the first companies to produce antigens for the newly identified SARS-CoV-2 virus that causes COVID-19. By early April, the Company had successfully scaled production for mass use in diagnostic and vaccine development, and in July the Company was acquired by a global life sciences company for more than £18m.

Invex is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. 

The Binding Site provides specialist diagnostic products to clinicians and laboratory professionals worldwide. They are dedicated to improving patient lives, delivering innovative medical solutions that improve the diagnosis and management of blood cancers and immune system disorders.

Revitope Oncology Inc is revolutionizing immunotherapy to safely and effectively treat more cancers, bringing hope to patients for healthier and longer lives.